SB
LENZ
Samsara BioCapital’s LENZ Therapeutics LENZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Sell |
343,012
-183,378
| -35% | -$5.37M | 2.06% | 9 |
|
|
2025
Q1 | $13.5M | Sell |
526,390
-460,591
| -47% | -$11.8M | 2.41% | 9 |
|
|
2024
Q4 | $28.5M | Sell |
986,981
-221,492
| -18% | -$6.39M | 3.91% | 7 |
|
|
2024
Q3 | $28.7M | Hold |
1,208,473
| – | – | 5.51% | 7 |
|
|
2024
Q2 | $20.9M | Hold |
1,208,473
| – | – | 4.37% | 8 |
|
|
2024
Q1 | $27M | Sell |
1,208,473
-7,250,841
| -86% | -$162M | 4.17% | 7 |
|
|
2023
Q4 | $22.2M | Hold |
8,459,314
| – | – | 3.45% | 7 |
|
|
2023
Q3 | $21M | Hold |
8,459,314
| – | – | 6.42% | 6 |
|
|
2023
Q2 | $22M | Hold |
8,459,314
| – | – | 3.86% | 5 |
|
|
2023
Q1 | $20.7M | Hold |
8,459,314
| – | – | 4.28% | 5 |
|
|
2022
Q4 | $28.1M | Hold |
8,459,314
| – | – | 6.04% | 4 |
|
|
2022
Q3 | $26.8M | Hold |
8,459,314
| – | – | 6.25% | 4 |
|
|
2022
Q2 | $23.3M | Buy |
8,459,314
+386,711
| +5% | +$1.06M | 6.2% | 4 |
|
|
2022
Q1 | $41.2M | Buy |
8,072,603
+220,670
| +3% | +$1.13M | 10.36% | 2 |
|
|
2021
Q4 | $97.6M | Buy |
7,851,933
+420,310
| +6% | +$5.22M | 18.93% | 1 |
|
|
2021
Q3 | $122M | Hold |
7,431,623
| – | – | 19.11% | 1 |
|
|
2021
Q2 | $228M | Buy |
+7,431,623
| New | +$228M | 28.19% | 1 |
|